Search Results - "Laitman, Adam"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    S791 An Association Between IBS Quality of Life Score and Symptoms of Abdominal Pain, Bloating, and Cramping in IBS-C: A Pooled Phase 3 Trial Correlation Analysis

    S791 An Association Between IBS Quality of Life Score and Symptoms of Abdominal Pain, Bloating, and Cramping in IBS-C: A Pooled Phase 3 Trial Correlation Analysis by Shah, Eric, Laitman, Adam P., Halton, Patricia, McQueen, Angela, Goyal, Deepinder

    Published in The American journal of gastroenterology (01-10-2024)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    S532 Plecanatide Improves Severe Abdominal Pain and Severe Bloating in Individuals With Irritable Bowel Syndrome With Constipation (IBS-C): A Pooled Analysis of Two Phase 3 Trials

    S532 Plecanatide Improves Severe Abdominal Pain and Severe Bloating in Individuals With Irritable Bowel Syndrome With Constipation (IBS-C): A Pooled Analysis of Two Phase 3 Trials by Sayuk, Gregory, Chokshi, Reena, Laitman, Adam, Allen, Christopher, Brenner, Darren

    Published in The American journal of gastroenterology (01-10-2022)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    S799 Plecanatide Is Efficacious in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) and Bloating: Evaluation Using Trisymptom Composite Endpoints

    S799 Plecanatide Is Efficacious in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) and Bloating: Evaluation Using Trisymptom Composite Endpoints by Brenner, Darren M., Shin, Andrea S., Laitman, Adam P., Kunkel, David C.

    Published in The American journal of gastroenterology (01-10-2024)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    S534 Plecanatide Improves Symptoms of Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome With Constipation (IBS-C) Across Age Subgroups: An Analysis of Four Phase 3 Trials

    S534 Plecanatide Improves Symptoms of Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome With Constipation (IBS-C) Across Age Subgroups: An Analysis of Four Phase 3 Trials by Staller, Kyle, Laitman, Adam, Allen, Christopher, Neshatian, Leila, Chey, William D, Chang, Lin

    Published in The American journal of gastroenterology (01-10-2022)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo‐controlled trials in adults with severe constipation

    Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo‐controlled trials in adults with severe constipation by Cash, Brooks D., Sharma, Amol, Walker, Anna, Laitman, Adam P., Chang, Lin

    Published in Neurogastroenterology and motility (01-09-2023)
    “…Background Patients with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS‐C) often experience severe symptoms. The…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation

    Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation by Brenner, Darren M., Sharma, Amol, Rao, Satish S. C., Laitman, Adam P., Heimanson, Zeev, Allen, Christopher, Sayuk, Gregory S.

    Published in Digestive diseases and sciences (01-05-2024)
    “…Background Bloating is a bothersome symptom in irritable bowel syndrome with constipation (IBS-C). Aim To evaluate plecanatide efficacy in patients with IBS-C…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  7. 7
    Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide

    Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide by Rao, Satish S.C., Laitman, Adam P., Miner, Philip B.

    “…Chronic idiopathic constipation (CIC) is a common condition that affects some patient groups more often. Demographic/clinical characteristics can differ in…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  8. 8
    Plecanatide Improves Symptoms of Irritable Bowel Syndrome with Constipation: Results of an Integrated Efficacy and Safety Analysis of Two Phase 3 Trials

    Plecanatide Improves Symptoms of Irritable Bowel Syndrome with Constipation: Results of an Integrated Efficacy and Safety Analysis of Two Phase 3 Trials by Brenner, Darren M, Dorn, Spencer D, Fogel, Ronald P, Christie, Jennifer, Laitman, Adam P, Rosenberg, Jonathan

    Published in International journal of general medicine (30-09-2023)
    “…Purpose: Patients with irritable bowel syndrome with constipation (IBS-C) experience abdominal pain with altered bowel movements. Plecanatide is indicated as…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  9. 9
    Safe Management of Adverse Effects Associated with Prescription Opioids in the Palliative Care Population: A Narrative Review

    Safe Management of Adverse Effects Associated with Prescription Opioids in the Palliative Care Population: A Narrative Review by Zimmerman, Amanda, Laitman, Adam

    Published in Journal of clinical medicine (07-05-2024)
    “…In the palliative care population, prescription opioids are often considered viable pain relief options. However, in this complex patient population, the…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  10. 10
    AMISELIMOD FOR THE TREATMENT OF ACTIVE ULCERATIVE COLITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

    AMISELIMOD FOR THE TREATMENT OF ACTIVE ULCERATIVE COLITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL by Hanauer, Stephen B., Laitman, Adam P., Heimanson, Zeev, Israel, Robert J., Lee, Jimin, Schreiber, Stefan

    Published in Gastroenterology (New York, N.Y. 1943) (18-05-2024)
    Get full text
    Journal Article
    Save to List
    Saved in:
  11. 11
    Tu1617 PLECANATIDE IMPROVES ABDOMINAL PAIN, BLOATING, AND STRAINING SYMPTOMS IN ADULTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C): A NEW COMPOSITE ENDPOINT ANALYSIS OF TWO RANDOMIZED, PHASE 3 TRIALS

    Tu1617 PLECANATIDE IMPROVES ABDOMINAL PAIN, BLOATING, AND STRAINING SYMPTOMS IN ADULTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C): A NEW COMPOSITE ENDPOINT ANALYSIS OF TWO RANDOMIZED, PHASE 3 TRIALS by Brenner, Darren M., Poppers, David, Laitman, Adam P., Allen, Christopher, Shah, Eric D.

    Published in Gastroenterology (New York, N.Y. 1943) (01-05-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  12. 12
    Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide

    Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide by Rao, Satish S.C., Laitman, Adam P., Miner, Philip B.

    Get full text
    Journal Article
    Save to List
    Saved in:
  13. 13
    Opioid Related Endocrinopathy

    Opioid Related Endocrinopathy by Gudin, Jeffrey A., Laitman, Adam, Nalamachu, Srinivas

    Published in Pain medicine (Malden, Mass.) (01-10-2015)
    “…Objective Millions of patients continue to require opioid analgesics for control of moderate to severe chronic pain, which is a disease that affects more…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  14. 14
    Opioid Related Endocrinopathy: Table 1

    Opioid Related Endocrinopathy: Table 1 by Gudin, Jeffrey A., Laitman, Adam, Nalamachu, Srinivas

    Published in Pain medicine (Malden, Mass.) (01-10-2015)
    Get full text
    Journal Article
    Save to List
    Saved in:
  15. 15
    PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF AMISELIMOD, A SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 STUDY

    PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF AMISELIMOD, A SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 STUDY by Lee, Jimin, Lester, Robert, Lowe, Ezra, Franklin, Howard, Israel, Robert, Laitman, Adam

    Published in Gastroenterology (New York, N.Y. 1943) (01-04-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  16. 16
    PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF AMISELIMOD, A SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 STUDY

    PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF AMISELIMOD, A SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 STUDY by Lee, Jimin, Lester, Robert, Lowe, Ezra, Franklin, Howard, Israel, Robert, Laitman, Adam

    Published in Inflammatory bowel diseases (26-01-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: